DMKC Advisory Services LLC Has $3.33 Million Stock Position in Procter & Gamble Company (The) $PG

DMKC Advisory Services LLC increased its holdings in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 18.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 22,728 shares of the company’s stock after buying an additional 3,590 shares during the quarter. DMKC Advisory Services LLC’s holdings in Procter & Gamble were worth $3,333,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Carson Advisory Inc. grew its position in shares of Procter & Gamble by 0.5% in the 4th quarter. Carson Advisory Inc. now owns 12,124 shares of the company’s stock valued at $1,738,000 after purchasing an additional 65 shares during the period. Trilogy Capital Inc. raised its holdings in Procter & Gamble by 1.1% during the 4th quarter. Trilogy Capital Inc. now owns 6,289 shares of the company’s stock worth $901,000 after buying an additional 67 shares during the period. Cary Street Partners Investment Advisory LLC lifted its stake in Procter & Gamble by 1.8% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 3,829 shares of the company’s stock valued at $549,000 after buying an additional 67 shares in the last quarter. Lorne Steinberg Wealth Management Inc. boosted its holdings in shares of Procter & Gamble by 2.7% in the fourth quarter. Lorne Steinberg Wealth Management Inc. now owns 2,623 shares of the company’s stock valued at $376,000 after buying an additional 68 shares during the period. Finally, Grant Street Asset Management Inc. increased its position in shares of Procter & Gamble by 2.7% during the fourth quarter. Grant Street Asset Management Inc. now owns 2,627 shares of the company’s stock worth $376,000 after acquiring an additional 69 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on PG shares. The Goldman Sachs Group lowered their target price on Procter & Gamble from $159.00 to $155.00 and set a “neutral” rating for the company in a report on Wednesday, April 8th. Wells Fargo & Company lifted their target price on Procter & Gamble from $158.00 to $164.00 and gave the company an “overweight” rating in a research report on Monday, April 27th. Barclays upped their price target on Procter & Gamble from $146.00 to $152.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 21st. Rothschild & Co Redburn cut their price objective on shares of Procter & Gamble from $157.00 to $155.00 and set a “neutral” rating on the stock in a research report on Monday, April 27th. Finally, Morgan Stanley reduced their target price on shares of Procter & Gamble from $175.00 to $166.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Thirteen investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $161.52.

Read Our Latest Report on Procter & Gamble

Procter & Gamble Price Performance

NYSE:PG opened at $146.79 on Thursday. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $167.25. The firm has a market capitalization of $341.81 billion, a price-to-earnings ratio of 22.17, a P/E/G ratio of 4.55 and a beta of 0.39. The stock’s 50 day moving average price is $147.80 and its two-hundred day moving average price is $148.99. The company has a quick ratio of 0.47, a current ratio of 0.68 and a debt-to-equity ratio of 0.42.

Procter & Gamble (NYSE:PGGet Free Report) last issued its earnings results on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, topping the consensus estimate of $1.41 by $0.02. The company had revenue of $21.20 billion during the quarter, compared to the consensus estimate of $21.38 billion. Procter & Gamble had a return on equity of 31.25% and a net margin of 18.44%.The firm’s revenue for the quarter was up 1.5% compared to the same quarter last year. During the same period in the previous year, the company posted $1.48 EPS. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, analysts anticipate that Procter & Gamble Company will post 6.99 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, August 17th. Shareholders of record on Friday, July 24th will be issued a $1.0885 dividend. This represents a $4.35 annualized dividend and a dividend yield of 3.0%. The ex-dividend date is Friday, July 24th. Procter & Gamble’s payout ratio is currently 65.71%.

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: P&G agreed to acquire premium supplements company Thorne for $3.8 billion in cash. The transaction expands P&G’s health-care portfolio alongside brands such as Metamucil, Align and New Chapter, and gives the company greater exposure to premium wellness and younger consumers. The deal is expected to close later this year. P&G will acquire supplements brand Thorne
  • Positive Sentiment: Management and Thorne’s owner described the acquisition as a way to build on Thorne’s science-backed brand and growth in wellness. Investors initially viewed the purchase as a strategic move to diversify P&G beyond traditional household and personal-care products. L Catterton announces sale of Thorne to P&G
  • Neutral Sentiment: Trading activity in P&G call options increased, indicating heightened investor interest and potentially more bullish positioning around the acquisition. However, options activity alone does not establish a change in the company’s fundamentals. Traders purchase large volume of P&G call options
  • Negative Sentiment: P&G’s latest quarterly results showed a mixed picture: earnings per share of $1.43 topped estimates by $0.02, but revenue of $21.2 billion missed the $21.38 billion consensus and rose only 1.5% year over year. The sales shortfall and ongoing input-cost pressure may be limiting enthusiasm for the stock. PG Q2 deep dive
  • Negative Sentiment: The $3.8 billion cash purchase creates execution and valuation risk, including the challenge of integrating Thorne and generating sufficient growth from the premium supplement business. Investors may also be assessing the deal’s effect on P&G’s balance sheet and future returns.

About Procter & Gamble

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Read More

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.